Ignite Creation Date:
2024-05-06 @ 10:41 AM
Last Modification Date:
2024-10-26 @ 12:33 PM
Study NCT ID:
NCT03322969
Status:
UNKNOWN
Last Update Posted:
2021-02-26
First Post:
2017-10-24
Brief Title:
Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Study Overview
Official Title:
Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy Versus Receiving the Original Chemotherapy in Locally Advanced Gastric Cancer a Randomized Controlled Study
Status:
UNKNOWN
Status Verified Date:
2021-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
For patients undergoing postoperative therapy for locally advanced gastric cancer after neoadjuvant chemotherapy we assessed the utility of graded histologic regression of 50 as the criterion of treatment change Sixty patients will be enrolled to randomize into two groupsreceiving modified chemotherapy and receiving the original chemotherapy
Detailed Description:
For patients undergoing postoperative therapy for locally advanced gastric cancer after neoadjuvant chemotherapy we assessed the utility of graded histologic regression of 50 as the criterion of treatment change Sixty patients will be enrolled to randomize into two groupsreceiving modified chemotherapy and receiving the original chemotherapy Overall survival and disease-free survival will be observed between two groups
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None